Literature DB >> 12534872

Evaluation of dosage adjustment in patients with renal impairment.

P I Pillans1, P G Landsberg, A M Fleming, M Fanning, J M Sturtevant.   

Abstract

AIMS: To determine whether appropriate dosage adjustments are made in patients with significant renal impairment for drugs with a high fractional renal clearance.
METHODS: Evaluation of dosage adjustment was performed in patients who were admitted to a 480-bed metropolitan hospital (Princess Alexandra Hospital, Brisbane, Australia) with an estimated creatinine clearance of < or =40 mL/min. All drugs had a high fractional renal excretion. A prescribed dose within 30% of the calculated dose was considered appropriate.
RESULTS: Doses were found to be inappropriately high in 111 (44.8%) of 248 admission prescriptions of the targeted drugs. Doses were appropriately reduced in hospital in 26 patients (23.4%). Seventy-three (29.3%) prescriptions were continued with excessive doses. Only 34 prescriptions for the target drugs were initiated in hospital, of which 88.2% were appropriately dosed.
CONCLUSIONS: A significant percentage of patients with renal impairment are admitted to hospital on inappropriately high doses of drugs, with a high fractional renal excretion and low therapeutic index. Doses are appropriately reduced in hospital in some patients but there is still room for improvement [corrected].

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12534872     DOI: 10.1046/j.1445-5994.2003.00330.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  18 in total

1.  Clinical relevance of information in the Summaries of Product Characteristics for dose adjustment in renal impairment.

Authors:  Teresa M Salgado; Blanca Arguello; Fernando Martinez-Martinez; Shalom I Benrimoj; Fernando Fernandez-Llimos
Journal:  Eur J Clin Pharmacol       Date:  2013-07-25       Impact factor: 2.953

Review 2.  Current progress in pharmacogenetics.

Authors:  John D Blakey; Ian P Hall
Journal:  Br J Clin Pharmacol       Date:  2011-06       Impact factor: 4.335

3.  Dose adjustment of cisplatin, etoposide, and ifosfamide according to kidney function: a retrospective analysis and implications for medication safety.

Authors:  Carolin Grafe; Sabine Semrau; Alexander Hein; Matthias W Beckmann; Andreas Mackensen; Frank Dörje; Martin F Fromm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-01-02       Impact factor: 3.000

4.  Impact of a clinical decision support system for drug dosage in patients with renal failure.

Authors:  Sophie Desmedt; Anne Spinewine; Michel Jadoul; Séverine Henrard; Dominique Wouters; Olivia Dalleur
Journal:  Int J Clin Pharm       Date:  2018-05-21

5.  Use of renal risk drugs in patients with renal impairment.

Authors:  Hilde Holm; Kirsti Bjerke; Lone Holst; Liv Mathiesen
Journal:  Int J Clin Pharm       Date:  2015-08-18

Review 6.  Estimating renal function to reduce the risk of adverse drug reactions.

Authors:  Andrea Corsonello; Graziano Onder; Silvia Bustacchini; Mauro Provinciali; Sabrina Garasto; Pietro Gareri; Fabrizia Lattanzio
Journal:  Drug Saf       Date:  2012-01       Impact factor: 5.606

Review 7.  A composite screening tool for medication reviews of outpatients: general issues with specific examples.

Authors:  Peter A G M De Smet; Wilma Denneboom; Cees Kramers; Richard Grol
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

8.  Prediction of Kidney Drug Clearance: A Comparison of Tubular Secretory Clearance and Glomerular Filtration Rate.

Authors:  Yan Chen; Leila R Zelnick; Andrew N Hoofnagle; Catherine K Yeung; Laura M Shireman; Brian Phillips; Calder C Brauchla; Ian de Boer; Linda Manahan; Susan R Heckbert; Jonathan Himmelfarb; Bryan R Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2020-11-25       Impact factor: 10.121

9.  Appropriateness of drug dose and frequency in patients with renal dysfunction in a tertiary care hospital: A cross-sectional study.

Authors:  Arpit Prajapati; Barna Ganguly
Journal:  J Pharm Bioallied Sci       Date:  2013-04

10.  Medication safety in acute care in Australia: where are we now? Part 1: a review of the extent and causes of medication problems 2002-2008.

Authors:  Elizabeth E Roughead; Susan J Semple
Journal:  Aust New Zealand Health Policy       Date:  2009-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.